000			01232 a2200373 4500
005			20250514023552.0
264		0	_c20020315
008			200203s 0 0 jpn d
022			_a0047-1852
040			_aNLM _beng _cNLM
100	1		_aMutoh, Hiroyuki
245	0	0	_a[Duodenal ulcer]. _h[electronic resource]
260			_bNihon rinsho. Japanese journal of clinical medicine _cJan 2002
300			_a151-60 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAge Factors
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects
650	0	4	_aAnti-Ulcer Agents _xtherapeutic use
650	0	4	_aDuodenal Ulcer _xepidemiology
650	0	4	_aFamotidine _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHelicobacter Infections _xcomplications
650	0	4	_aHelicobacter pylori
650	0	4	_aHistamine H2 Antagonists _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aJapan _xepidemiology
650	0	4	_aMale
650	0	4	_aOmeprazole _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aSex Factors
650	0	4	_aTime Factors
700	1		_aSugano, Kentaro
773	0		_tNihon rinsho. Japanese journal of clinical medicine _gvol. 60 Suppl 1 _gp. 151-60
999			_c11747086 _d11747086